Chemistree Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chemistree Technology (TSE:CHM) has released an update. Chemistree Technology Inc. has announced the approval from its debentureholders to proceed ...

/PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is providing Notice of the semi-annual payment of...

/PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is providing Notice of the semi-annual payment of...

As a Latino advocacy group met with a federal regulator Tuesday to discuss their concerns about alleged abuses perpetrated by Herbalife (NYSE: HLF) against Latinos and others, hedge-fund manager Bill Ackman continued his efforts to portray the company as an illegal pyramid scheme. This time... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

Share this article Share this article VANCOUVER, BC, Feb. 8, 2021 /PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). "ImmunoFlex is now recruiting patients into a Phase 4 clinical trial designed to optimize the impact of FLEX 20 TM on the immune system. The ...